{"nct_id":"NCT01348919","title":"Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2011-08-03","start_date_type":"ACTUAL","primary_completion_date":"2013-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2013-03-14","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["TEVA"]}